Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SAGE | Common Stock | Options Exercise | $13.9K | +30.9K | +36.46% | $0.45* | 116K | Apr 27, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SAGE | Stock Option (Right to Buy) | Options Exercise | $0 | -30.9K | -72.66% | $0.00 | 11.6K | Apr 27, 2022 | Common Stock | 30.9K | $0.45 | Direct | F1 |
Id | Content |
---|---|
F1 | The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on August 12, 2017. |